E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/5/2012 in the Prospect News PIPE Daily.

AtheroNova completes $2.5 million of $2.84 million placement of units

Company sells common shares with four-year warrants at $0.50 per unit

By Devika Patel

Knoxville, Tenn., Oct. 5 - AtheroNova Inc. settled a $2.5 million tranche of a $2.84 million private placement of units on Oct. 1, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company sold 5 million units of one common share and a half-share warrant at $0.50 per unit. It plans to sell 670,000 additional units in future tranches.

The whole warrants are each exercisable at $0.625 for four years. The strike price is a 23.78% discount to the Sept. 28 closing share price of $0.82.

Settlement of the final tranche is expected Oct. 31.

AtheroNova, formerly Trist Holdings Inc., is a Van Nuys, Calif., development stage company that is developing products to address the treatment of atherosclerosis through the use of natural compounds and their derivatives.

Issuer:AtheroNova Inc.
Issue:Units of one common share and a half-share warrant
Amount:$2,835,000
Units:5.67 million
Price:$0.50
Warrants:One half-share warrant per unit
Warrant expiration:Four years
Warrant strike price:$0.625
Settlement date:Oct. 1 (for $2.5 million), Oct. 31 (final tranche)
Stock symbol:OTCBB: AHRO
Stock price:$0.82 at close Sept. 28
Market capitalization:$22.37 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.